Page last updated: 2024-10-24

peptidyl-aspartic acid hydroxylation

Definition

Target type: biologicalprocess

The hydroxylation of peptidyl-aspartic acid to form peptidyl-hydroxyaspartic acid. [GOC:mah]

Peptidyl-aspartic acid hydroxylation is a post-translational modification that involves the enzymatic addition of a hydroxyl group to the β-carbon of an aspartic acid residue within a polypeptide chain. This process is catalyzed by specific enzymes known as peptidyl-aspartate hydroxylases.

The reaction mechanism typically involves the following steps:

1. **Substrate Binding:** The peptidyl-aspartate hydroxylase enzyme binds to the peptide substrate, recognizing the aspartic acid residue to be hydroxylated.

2. **Oxygen Activation:** The enzyme utilizes molecular oxygen (O2) to activate the hydroxyl group that will be added to the aspartic acid.

3. **Hydroxylation:** The activated hydroxyl group is transferred from the enzyme to the β-carbon of the aspartic acid residue, forming a β-hydroxyaspartic acid.

4. **Product Release:** The hydroxylated peptide product is released from the enzyme, allowing for further processing or biological activity.

Peptidyl-aspartic acid hydroxylation plays a crucial role in a variety of biological processes, including:

* **Protein Folding and Stability:** Hydroxylation can influence the conformation and stability of proteins by introducing a new polar hydroxyl group, altering interactions with other amino acids.

* **Signal Transduction:** Hydroxylated aspartic acid residues can serve as recognition sites for specific proteins or enzymes, mediating signal transduction pathways.

* **Enzyme Activity:** Hydroxylation can modulate the activity of enzymes by altering their substrate specificity or catalytic efficiency.

* **Cellular Differentiation:** Hydroxylation can be involved in the differentiation of cells by regulating the expression or activity of specific proteins.

The importance of peptidyl-aspartic acid hydroxylation is evident in the association of defects in this process with various human diseases, including neurodegenerative disorders and cardiovascular diseases.

In summary, peptidyl-aspartic acid hydroxylation is a critical post-translational modification that can significantly impact the structure, function, and activity of proteins, playing a key role in diverse biological processes.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Aspartyl/asparaginyl beta-hydroxylaseAn aspartyl/asparaginyl beta-hydroxylase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q12797]Homo sapiens (human)

Compounds (10)

CompoundDefinitionClassesRoles
gossypolGossypol: A dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer.
2,4-pyridinedicarboxylic acidlutidinic acid : A pyridinedicarboxylic acid carrying carboxy groups at positions 2 and 4.pyridinedicarboxylic acid
bleomycinbleomycinantineoplastic agent;
metabolite
tubacintubacin: inhibits histone deacetylase 6; structure in first source1,3-oxazoles
belinostathydroxamic acid;
olefinic compound;
sulfonamide
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
midostaurinmidostaurin : An organic heterooctacyclic compound that is the N-benzoyl derivative of staurosporine.benzamides;
gamma-lactam;
indolocarbazole;
organic heterooctacyclic compound
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
abt-737aromatic amine;
aryl sulfide;
biphenyls;
C-nitro compound;
monochlorobenzenes;
N-arylpiperazine;
N-sulfonylcarboxamide;
secondary amino compound;
tertiary amino compound
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
navitoclaxaryl sulfide;
monochlorobenzenes;
morpholines;
N-sulfonylcarboxamide;
organofluorine compound;
piperazines;
secondary amino compound;
sulfone;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
plx4032aromatic ketone;
difluorobenzene;
monochlorobenzenes;
pyrrolopyridine;
sulfonamide
antineoplastic agent;
B-Raf inhibitor
abt-199venetoclax : A member of the class of pyrrolopyridines that is a potent inhibitor of the antiapoptotic protein B-cell lymphoma 2. It is used for treamtment of chronic lymphocytic leukemia with 17p deletion.

venetoclax: A BCL-2 inhibitor with antineoplastic activity that is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA associated with chromosome 17p deletion; structure in first source.
aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
N-sulfonylcarboxamide;
oxanes;
pyrrolopyridine
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor